Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to $807000.0.

  • IceCure Medical's Share-based Compensation rose 23625.0% to $807000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 3861.49%. This contributed to the annual value of $869000.0 for FY2024, which is 3366.41% down from last year.
  • According to the latest figures from Q3 2025, IceCure Medical's Share-based Compensation is $807000.0, which was up 23625.0% from $170000.0 recorded in Q2 2025.
  • In the past 5 years, IceCure Medical's Share-based Compensation ranged from a high of $807000.0 in Q3 2025 and a low of $62000.0 during Q4 2021
  • Over the past 5 years, IceCure Medical's median Share-based Compensation value was $245000.0 (recorded in 2024), while the average stood at $287473.7.
  • Per our database at Business Quant, IceCure Medical's Share-based Compensation surged by 72580.65% in 2022 and then tumbled by 4897.96% in 2025.
  • Over the past 5 years, IceCure Medical's Share-based Compensation (Quarter) stood at $62000.0 in 2021, then surged by 725.81% to $512000.0 in 2022, then crashed by 40.82% to $303000.0 in 2023, then dropped by 27.72% to $219000.0 in 2024, then soared by 268.49% to $807000.0 in 2025.
  • Its last three reported values are $807000.0 in Q3 2025, $170000.0 for Q2 2025, and $125000.0 during Q1 2025.